The inv(16) acute myeloid leukemia associated CBFβ-MYH11 fusion is proposed to block 32 normal myeloid differentiation, but whether this subtype of leukemia cells is poised for a 33 unique cell lineage remains unclear. Here, we surveyed the functional consequences of CBFβ-34 MYH11 in primary inv(16) patient blasts, upon expression during hematopoietic 35 differentiation in vitro and upon knockdown in cell lines by multi-omics profiling. Our results 36 reveal that primary inv(16) AML cells share common transcriptomic signatures and 37 epigenetic determiners with megakaryocytes and erythrocytes. Using in vitro differentiation 38 systems, we reveal that CBFβ-MYH11 knockdown interferes with normal megakaryocyte 39 maturation. Two pivotal regulators, GATA2 and KLF1, are identified to complementally 40 occupy RUNX1 binding sites upon fusion protein knockdown, and overexpression of GATA2 41 partly restores megakaryocyte directed differentiation suppressed by CBFβ-MYH11. 42
Core-binding transcription factors (CBFs) have been proposed to shape both stem cell self-49 renewal and differentiation, and their dysfunction could potentially lead to cancer 50 pathogenesis 1 . The CBFs are heterodimeric complexes composed of two distinct subunits, 51 alpha and beta 2 . The CBF α subunit is encoded by the RUNX family (usually 52 RUNX1/AML1 in the hematopoietic cells) and directly contacts the DNA sequence, whereas 53 the non-DNA-binding CBF β subunit is thought to facilitate stabilizing the DNA affinity of 54 the CBF complex. CBFs are often mutated in acute myeloid leukemia (AML), for example in 55 t(8;21) AMLs, characterized by expression of the AML1-ETO fusion gene, or inv(16) AMLs, 56 delineated by the presence of the CBFβ-MYH11 (CM) event 3 . CBFβ-MYH11, encodes a 57 fusion protein between CBFβ and smooth muscle myosin heavy chain (SMMHC/MYH11), 58 and is associated with AML FAB subtype M4Eo accounting for around 6% of AML cases 4-6 . 59
However, our understanding of its roles in leukemogenesis remains incomplete. 60 61 72 At the molecular level, CBFβ-MYH11 in a complex with RUNX1 acts as a transcriptional 73 regulator, which can depend on local genomic context, activate and repress genes involved in 74 self-renewal, differentiation and ribosomal biogenesis 6, 11, 12 . Our previous findings have 75
shown that a variety of cell surface markers increase in expression levels upon knockdown of 76 CBFβ-MYH11 in the inv(16) cells, including those for the monocytic and megakaryocytic 77 lineages 11 . In addition, mouse studies revealed that expression of the CBFβ-MYH11 protein 78 causes abnormal erythropoiesis and gives rise to preleukemic pre-megakaryocyte/erythrocyte 79 progenitors 8, 13 . Overall, these results potentially implicate a role of the CBFβ-MYH11 fusion 80 in skewing cell differentiation orientation. Figure 1A) . The main source of 150 variability (PC1) was the difference between Mega/Ery and CD34/inv(16) cells ( Figure 1A) , 151 with the top contributing genes in PC1 mainly involved in immune response terms. In contrast, 152 the second component (PC2) showed significant similarity between inv(16) and Mega/Ery, 153
and was enriched in cell differentiation related terms ( Figure 1A ). The transcriptional 154 difference between inv(16) leukemic blasts and normal cells was revealed by PC3, which 155 terms associated with leukocyte migration and activation. Each pairwise comparison between 156 individual normal cell type and inv(16) blasts revealed more than 2,000 differentially 157 expressed genes ( Figure 1B , and Supplementary Table 1 ). Together, these results suggest that 158 inv(16) AMLs carry unique gene expression signatures (PC3), but also signatures that 159 resemble CD34 + progenitor cells (PC1) or mature cells such as megakaryocytes (PC2). 160 161 Next, all differentially expressed genes were clustered into eight groups by the k-means 162 clustering method (Supplementary Figure 1B , C). Besides cell-type-specific clusters (C1, C4, 163 C6 and C8), we again found that inv(16) blasts shared gene signatures with normal cell types. 164
For instance, the C2 cluster revealed similar expression patterns between inv(16) and CD34 + 165 progenitors, while the inv(16) genes expressed in C3 resembled more closely a Mono 166 signature. Furthermore, the primary inv(16) blasts shared a subset of gene signatures with 167 Mega/Ery as shown in the C5 and C7 cluster ( Figure 1C ), although these genes also displayed 168 similar expression levels in CD34 or Mono. These findings indicate that inv(16) blasts 169 maintained certain transcriptional signatures from progenitors, but also already obtained 170 characteristics of mature cells. 171 172 Different hematopoietic cell types can be identified by examining expression of cluster of 173 differentiation (CD) markers. Here, we identified 236 CD markers differentially expressed 174 between inv(16) and normal cells. Our previous studies showed altered transcriptional activity 175 of CD markers upon transient knockdown of CBFβ-MYH11 in ME-1 cells 11 . To examine 176 whether the 236 differentially expressed CD markers from this study might be directly 177 regulated by CBFβ-MYH11 we compared the two datasets. More than half of CBFβ-MYH11 178 dependent CD markers (84/130) were also differentially expressed in the comparison of 179 normal cell types versus inv(16) AMLs ( Figure 1D ), suggesting putative regulation by CBFβ-180 MYH11. Amongst these, myeloid stem cell markers like CD34 and CD133 displayed 181 significantly higher expression levels in inv(16) AML than other mature cells ( Figure 1E ). 182
However, some markers of mature cells like CD64 and CD71 were also expressed in inv(16) 183 AML, suggesting inv(16) cells might already be partly differentiated. 184
185
To extend this finding we examined several other marker genes involved in hematopoiesis 186 including GFI1B, RUNX1 and GATA2 ( Supplementary Figure 2A ). It has been shown that 187 expression of GFI1B is key to megakaryocyte and platelet development 20 . Moreover, CBFβ-188 MYH11 binds a putative downstream regulatory element of GFI1B gene 11 (Supplementary 189 Figure 2B ). We confirmed the highest transcriptional level of GFI1B in Ery/Mega, but also 190 found that the inv(16) blasts expressed higher levels of GFI1B as compared to Mono, and 191 similar to CD34 progenitors ( Supplementary Figure 2A Mono. In addition, we downloaded public ATAC-seq data 21 , which showed high consistency 201
with DNaseI-seq (Supplementary Figure 3A 4A). We could show that the oligonucleotide with the RUNX1 motif efficiently pulled down 283
CBFβ-MYH11 as well as RUNX1 and CBFβ from an ME-1 cell lysate ( Figure 5A ), whereas 284 significantly attenuated affinity for CBFβ-MYH11 was observed when the knockdown cell 285 lysate was used. Importantly, knockdown of CBFβ-MYH11 did not affect RUNX1 and wild-286 type CBFβ occupancy, suggesting changes in protein binding profiles are likely due to the 287 absence of CBFβ-MYH11. 288
289
To decipher the interactome of the CBFβ-MYH11 complex at RUNX1 binding sites, we 290 employed previously described SILAC-based technology 11, 29 , using extracts derived from 291
CBFβ-MYH11-knockdown ME-1 cells grown in light (L) or heavy (H)-labelled medium, 292 incubated with oligonucleotides containing the RUNX1 motif (see Methods section). Of the 293 1,300 identified proteins at a high confidence level, only a limited number displayed highly 294 significant SILAC-ratios ( 2) as CBFβ-MYH11 interactors. The CBFβ-MYH11 complex 295 seems to facilitate the recruitment of MYH9 and MYL6 proteins to RUNX1 sites, as shown 296 by their enrichment in the pull-down assay from ME-1 lysates ( Figure 5B ). Interestingly, 297 upon CBFβ-MYH11 knockdown, two transcription factors (TFs), GATA2 and KLF1, are 298 strongly enriched at RUNX1 occupancy loci, implying that these might play a crucial role in 299 coordinating the RUNX1-dependent regulatory network in normal cells. Our previous 300 findings demonstrated that GATA2 and KLF1 displayed enhanced levels in transcription after 301 CBFβ-MYH11 knockdown 11 , and the present work could confirm not only increased RNA 302 expression, but also stronger binding to the RUNX1 containing oligo by western blot 303 (Supplementary Figure 5A, B ), suggesting that the two TFs are repressed and might be 304 replaced by CBFβ-MYH11 fusion in inv(16) AML. These findings are further supported by 305 our previous inability to detect GATA2 and KLF1 as binders of RUNX1 sites 11 , as these 306 assays were also done in the presence of CBFβ-MYH11. 307 308 GATA2/CBFβ-MYH11 switching drives megakaryocyte/erythrocyte differentiation 309 310 As GATA2 is the highest expressed GATA factor in ME-1 cells, we investigated the genome-311 wide binding pattern by ChIP-seq in control and CBFβ-MYH11-knockdown inv(16) cells, 312 and also examined the RUNX1 binding profile in parallel. The genome-wide screen indicated 313 that GATA2 occupied similar genomic regions as RUNX1 at most locations. Quantifying 314 GATA2 occupancy at RUNX1 loci revealed 2,410 sites with increased GATA2 signal and 315 only 25 reduced binding sites. The 2,410 regions showed increased RUNX1 occupancy but 316 reduced CBFβ-MYH11 binding ( Figure 6A ), and associated genes were involved in 317 megakaryocyte/erythrocyte differentiation and platelet formation. Furthermore, genes 318 associated with the 2,410 regions were increased in expression levels, which was further 319 reflected by elevated occupancy level of the H3K27ac mark ( Figure 6B, C) , indicating 320 activation of the GATA2-target gene program after the knockdown of CBFβ-MYH11. As 321 could be expected, motif discovery at these regions presented remarkable enrichment for the 322 GATA motif ( Figure 6D ). In addition, also overrepresentation for the EGR motif was 323 detected, suggesting that TFs binding this motif are potentially involved in modulating the 324 gene transcription process in a synergistic manner ( Figure 6D ). 325
326
To probe whether enforced GATA2 expression is sufficient to switch on this gene program, 327 we transduced ME-1 cells with a GATA2 expression construct and performed global RNA-seq 328 analysis. During hematopoiesis, overexpression of GATA2 shows a decrease in cell 329 proliferation and induces differentiation toward the megakaryocyte lineage 30 . Here, global 330 transcriptional analysis identified a total of 367 genes increased and 171 genes decreased in 331 transcriptional levels after GATA2 overexpression ( Figure 6E ). As expected, these 332 upregulated genes contained GATA2 and several specific marker genes linked to 333 megakaryocytic/erythrocyte differentiation, such as CD61, HBD, HBB, EGR1 and GATA1 334 ( Figure 6F We have shown previously that CBFβ-MYH11 could activate transcription of self-renewal 366 genes, and also repress expression of differentiation markers in the context of the cell line 367 model ME-1 11 . Here, we used in vitro models with a single mutation (expression of CBFβ-368 MYH11) for surveying the role of CBFβ-MYH11. Using an iPSC system with dox-inducible 369
CBFβ-MYH11 revealed that this fusion is able to specifically block in vitro Mega/Ery 370 differentiation, but hardly has any effects on granulocyte and monocyte maturation. This 371 finding suggests expression of CBFβ-MYH11 affects specific cell differentiation pathways. 372
373
Previous studies have proposed that CBFβ-MYH11 impairs normal binding of other proteins 374 due to the higher affinity with RUNX1, and alters expression of RUNX1-dependent target 375 gene sets 11, 12, 33 . We found that GATA2 and KLF1 showed elevated expression levels 11 and 376 also acted as significant interactors of RUNX1 after CBFβ-MYH11 knockdown, suggesting 377 that CBFβ-MYH11 alters normal transcriptional programs of the two regulators and 378 competitively takes over their binding sites at RUNX1 occupancy loci. GATA2 and KLF1 379 exert key effects in the Mega/Ery lineage fate decision via interaction with other modulators 34-380 36 . Our RNA-seq analysis revealed attenuated expression levels of GATA2 and KLF1 in 381 inv(16) blasts as compared to Mega/Ery, and that GATA2 overexpression could partly restore 382 megakaryocyte differentiation, suggesting that weak expression of GATA2 is essential for 383 inv(16) leukemia but that increased levels are needed for differentiation. Focusing on GATA2, 384
ChIP-seq illuminated its transcriptional activation role at these RUNX1-dependent target 385 genes by increased recruitment of histone acetyltransferase activity and putative other TFs 386 like EGR1 37-39 . Consequently, the data suggests that the GATA2-involved binding/regulatory 387 program might be obstructed by the CBFβ-MYH11 fusion, leading to block of differentiation 388 towards Mega/Ery in inv(16) leukemogenesis. 389 390 Megakaryocyte and erythrocyte share plenty of common molecular signatures, but the two 391 cell types also exhibit distinct patterns in subtle regulatory networks 34, 40 . High transcription of 392 GATA2 has been reported to solely promote megakaryocyte differentiation and suppress 393 erythroid maturation 41 . In our study, GATA2 overexpression boosted expression levels of 394 some typical marker genes driving Mega differentiation but did not display a strong 395 correlation with results from CBFβ-MYH11 knockdown. This finding reveals that CBFβ-396 MYH11 interferes with coordinated orchestration of a precise balance of multiple factors in 397 maturing Mega/Ery, but the enforced expression of GATA2 only recapitulates megakaryocyte 398 differentiation during bifurcation of the two lineages. As a consequence, GATA2 alone is not 399 sufficient to inhibit CBFβ-MYH11-caused leukemia, and it maybe has greater functional 400 relevance only in context with overexpression of other regulators like KLF1. We thank all patients for their sample donations used in this study. We are grateful to Dr. Bert 419 van der Reijden for advice and discussion. This work was supported by the BLUEPRINT 420 
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